Aggregation-Inhibiting scFv-Based Therapies Protect Mice against AAV1/2-Induced A53T-α-Synuclein Overexpression.
Schlichtmann BW, Palanisamy BN, Malovic E, Nethi SK, Padhi P, Hepker M, Wurtz J, John M, Ban B, Anantharam V, Kanthasamy AG, Narasimhan B, Mallapragada SK.
Schlichtmann BW, et al. Among authors: anantharam v.
Biomolecules. 2023 Jul 31;13(8):1203. doi: 10.3390/biom13081203.
Biomolecules. 2023.
PMID: 37627268
Free PMC article.